C.M. Bebear
Laboratoire de Bactériologie
Université Victor Segalen Bordeaux 2
France
Name/email consistency: high
- Mechanisms of drug resistance in Mycoplasma pneumoniae. Bébéar, C.M., Pereyre, S. Curr. Drug. Targets. Infect. Disord (2005)
- DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Bébéar, C.M., Renaudin, H., Charron, A., Clerc, M., Pereyre, S., Bébéar, C. Antimicrob. Agents Chemother. (2003)
- Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas. Bebear, C.M., Renaudin, H., Bryskier, A., Bebear, C. Antimicrob. Agents Chemother. (2000)
- In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Bebear, C.M., Renaudin, H., Charron, A., Gruson, D., Lefrancois, M., Bebear, C. Antimicrob. Agents Chemother. (2000)
- Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin. Bébéar, C.M., Grau, O., Charron, A., Renaudin, H., Gruson, D., Bébéar, C. Antimicrob. Agents Chemother. (2000)
- Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Bebear, C.M., Renaudin, J., Charron, A., Renaudin, H., de Barbeyrac, B., Schaeverbeke, T., Bebear, C. Antimicrob. Agents Chemother. (1999)
- In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. Bébéar, C.M., Renaudin, H., Schaeverbeke, T., Leblanc, F., Bébéar, C. J. Antimicrob. Chemother. (1999)